Enhancement of Immune Responses by Co-delivery of CCL19/MIP-3beta Chemokine Plasmid With HCV Core DNA/Protein Immunization

BACKGROUND: Using molecular adjuvants offers an attractive strategy to augment DNA vaccine-mediated immune responses. Several studies have revealed that an efficient HCV vaccine model should be able to induce both humoral and cell mediated immune responses targeting the conserved regions of the viru...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartoonian, Christine, Sepehrizadeh, Zargham, Tabatabai Yazdi, Mojtaba, Jang, Yong Suk, Langroudi, Lida, Amir Kalvanagh, Parisa, Negahdari, Babak, Karami, Ali, Ebtekar, Massoumeh, Azadmanesh, Kayhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955266/
https://www.ncbi.nlm.nih.gov/pubmed/24693317
http://dx.doi.org/10.5812/hepatmon.14611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955266/
https://www.ncbi.nlm.nih.gov/pubmed/24693317
http://dx.doi.org/10.5812/hepatmon.14611

Ejemplares similares